OPMEDIC GROUP Inc. Announces its 7th consecutive Quarter of revenue and earnings growth



    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
    DISSEMINATION IN THE UNITED STATES./

    MONTREAL, Jan. 13 /CNW Telbec/ - OPMEDIC GROUP Inc. ("OPMEDIC GROUP")
(TSX: "OMG"), a healthcare-related company in fertility, laboratories and
surgeries providing services and facilities to patients and surgeons, is
pleased to announce financial results for the first quarter ended November 30,
2008.

    
    HIGHLIGHTS:

    - Revenue up by 25%. Revenue for the first quarter totalled
      $3.465 million compared to $2.761 million for the same period a year
      earlier.
    - Gross profit up by 23%. Gross profit for the first quarter totalled
      $1.909 million compared to $1.552 million for the same period a year
      earlier.
    - Net earnings up by 46%. Net earnings and net earnings per share for the
      first quarter were respectively $0.501 million and $0.03 compared to
      $0.342 million and $0.02 a year earlier.
    

    Revenue

    Revenue for the quarter ended November 30, 2008 totalled $3.465 million,
up by 25% or $0.704 million from $2.761 million for the same period a year
earlier. The Company's expansion projects continue to make a positive
contribution to revenue. In fact, the new cytology operations, following the
acquisition of Laboratoire Cyto-Stat in March 2008, generated additional
revenue of $0.312 million, and the surgical operations of the OPMEDIC division
resulted in additional revenue of $0.155 million partially because of the
opening of the new endoscopy rooms. The fertility division continued to grow
with additional revenue of $0.141 million, mainly as a result of an increase
in fertility cycle prices. Lastly, prenatal screening tests contributed
additional revenue totalling $0.096 million for the quarter, due equally to
higher prices and increased operations.

    Cost of Services

    The cost of services for the quarter rose by $0.348 million from $1.208
million in 2007 to $1.556 million in 2008. The new cytology operations
incurred additional expenses of $0.193 million in payroll, professional fees
and supplies, whereas the new endoscopic services available required
additional costs of $0.145 million, mainly to cover the cost of the new
premises, payroll and supplies.

    Gross Profit

    Gross profit for the quarter ended November 30, 2008 was $1.909 million,
up by 23% or $0.357 million from $1.552 million in 2007. Higher fertility and
cytology revenue added an extra $0.234 million, whereas increased operations
in the OPMEDIC division improved gross profit by $0.069 million.
    Gross profit to revenue for the quarter was 55% in 2008, versus 56% in
2007.

    General and Administrative Expenses

    General and administrative expenses for the quarter ended November 30,
2008 rose by $0.069 million to $0.832 million from $0.763 million in 2007.
Additional rent and payroll expenses were incurred as a result of the new
cytology and endoscopy operations.

    Net Earnings

    Net earnings and net earnings per share for the first quarter were
respectively $0.501 million and $0.03, compared to $0.342 million and $0.02 in
2007.

    Detailed financial results can be accessed on the OPMEDIC GROUP web site
at www.opmedicgroup.com.

    About OPMEDIC GROUP

    OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical and
endoscopic facilities and services to patients and surgeons (with its OPMEDIC
division), fertility treatments, medical imaging, laboratory services and
diagnostic procedures (with its PROCREA Cliniques division) and sperm banking
services (with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC
GROUP's Common Shares trade on the Toronto Stock Exchange under the symbol
"OMG".
    This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

    The Content of this press release has not been approved by nor submitted
    to the TSX which assumes no liability therefore.




For further information:

For further information: Jean-Marc Lachance, Vice President Finance and
Chief Financial Officer, (514) 345-8535, x 2260, jmlachance@opmedicgroup.com

Organization Profile

Opmedic Group Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890